Galderma announces first patient enrollment in study to assess nemolizumab in adults with Chronic Pruritus of Unknown Origin Press release
Galderma opens up new chapter for Sculptra® with MDR certification and new expanded indication for body Press release
ASDS 2025: Compelling new data on Restylane, Sculptra and Relfydess highlight Galderma’s innovative Injectable Aesthetics portfolio and pipeline Press release
Galderma receives U.S. FDA approval for Restylane® Lyft™ for the enhancement of the chin profile Press release
Galderma delivers record net sales of 3.737 billion USD in the first nine months of 2025 and 15.0% year-on-year growth at constant currency, raises full-year guidance Press release
AMWC Dubai: Galderma demonstrates Injectable Aesthetics leadership through updates on its scientific innovations and community education Press release
Galderma’s groundbreaking real-world study reveals the biological toll of modern living and urban environments on sensitive skin Press release
